Impaired functionality of HDL in diabetes

Diabetology International

Volumn 3, Issue 1, 2012, Pages 5-7

  Noto, Hiroshi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; FATTY ACID; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CELL ADHESION; CELL MIGRATION; CHOLESTEROL TRANSPORT; EDITORIAL; ENDOTHELIUM CELL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL;

EID: 84870368238     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-011-0059-2     Document Type: Editorial

References (14)

1. Miller M. Raising an isolated low HDL-C level: why, how, and when? Cleve Clin J Med. 2003; 70: 553-60.
2. Brewer HB Jr. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2004; 24: 387-91.
3. Noto H. Latest insights into high-density lipoprotein functions. The Endocrinologist. 2009; 19: 179-86.
4. Thompson A, Di Angelantonio E, Sarwar N, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Jama. 2008; 299: 2777-88.
5. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation. 2000; 101: 1907-12.
6. Stroes ES, van Wijk DF. Dalcetrapib: turning the tide for CETP inhibition? Lancet. 2011; 378: 1529-30.
7. Morgantini C, Natali A, Boldrini B, et al. Anti-inflammatory and antioxidant properties of HDLs are impaired in Type 2 diabetes. Diabetes. 2011; 60: 2617-23.
8. Garner B, Waldeck AR, Witting PK, et al. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem. 1998; 273: 6088-95.
9. Noto H, Hashimoto Y, Satoh H, et al. Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency. Biochem Biophys Res Commun. 2001; 289: 395-401.
10. Noto H, Hara M, Karasawa K, et al. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Arterioscler Thromb Vasc Biol. 2003; 23: 829-35.
11. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000; 102: 2165-8.
12. Wadham C, Albanese N, Roberts J, et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation. 2004; 109: 2116-22.
13. Park SH, Park JH, Kang JS, et al. Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol. 2003; 35: 168-82.
14. Navab M, Imes SS, Hama SY, et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991; 88: 2039-46.